Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 3/20 | 0.41 |
| ▸ | INPPL1 | O15357 | 3/20 | 0.38 |
| ▸ | INPP5A | Q14642 | 3/20 | 0.38 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.37 |
| ▸ | INPP5B | P32019 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL3426884 | 0.98 | SRC (0.40) | SRCINPPL1INPP5AHCRTR1INPP5B | |
| SCHEMBL1160132 | 0.95 | SRC (0.49) | SRCINPPL1INPP5AHCRTR1INPP5B | |
| SCHEMBL1609938 | 0.90 | CYP3A4 (0.44) | SRCALDH1A1 | |
| SCHEMBL6563116 | 0.89 | SRC (0.52) | SRCHCRTR1CES2CES1LMNA | |
| SCHEMBL3842119 | 0.89 | CES2 (0.46) | SRCINPPL1INPP5AINPP5BMAPT | |
| SCHEMBL272850 | 0.89 | INPPL1 (0.43) | SRCINPPL1INPP5AINPP5BMAPT | |
| SCHEMBL328975 | 0.84 | CES2 (0.42) | SRCINPPL1INPP5AINPP5BMAPT | |
| SCHEMBL295544 | 0.84 | TSHR (0.50) | SRCMAPTCES2CES1LMNA | |
| SCHEMBL25397512 | 0.83 | MEN1 (0.46) | SRCHCRTR1MAPTLMNAALDH1A1 | |
| SCHEMBL1011961 | 0.83 | MEN1 (0.41) | SRCINPPL1INPP5AINPP5BMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240174623-A1 | Build UP Film Curable Compositions | AGC Multi Material America, Inc. | 2024-05-30 | — | — | US | claimed |
| US-20240174802-A1 | Build UP Film Curable Compositions | AGC MULTI MAT AMERICA INC (US) | 2024-05-30 | — | — | US | claimed |
| US-20240174803-A1 | Curable Compositions | AGC Multi Material America, Inc. | 2024-05-30 | — | — | US | claimed |
| WO-2023164430-A1 | CURABLE COMPOSITIONS | AGC Multi Material America, Inc. (US) | 2023-08-31 | — | — | WO | claimed |
| US-20230265275-A1 | Curable Compositions | AGC Multi Material America, Inc. | 2023-08-24 | — | — | US | claimed |
| US-20210340352-A1 | LOW SMOKE HALOGEN FREE FLAME RETARDANT THERMOPLASTIC ELASTOMER COMPOSITIONS | CELANESE POLYMERS HOLDING, INC. | 2021-11-04 | — | — | US | claimed |
| US-11066533-B2 | Low smoke halogen free flame retardant thermoplastic elastomer compositions | DUPONT POLYMERS. INC. (US) | 2021-07-20 | — | — | US | claimed |
| EP-2859042-B1 | HALOGEN FREE FLAME RETARDANT THERMOPLASTIC ELASTOMER COMPOSITIONS HAVING IMPROVED INSULATION RESISTANCE | DU PONT (US) | 2020-09-23 | — | — | EP | claimed |
| US-20190139672-A1 | HALOGEN FREE FLAME RETARDANT THERMOPLASTIC ELASTOMER COMPOSITIONS HAVING IMPROVED INSULATION RESISTANCE | DU PONT (US) | 2019-05-09 | — | — | US | claimed |
| EP-3201263-B1 | LOW SMOKE HALOGEN FREE FLAME RETARDANT THERMOPLASTIC ELASTOMER COMPOSITIONS | DU PONT (US) | 2019-01-02 | — | — | EP | claimed |
| US-8759429-B2 | Flame-retardant copolyetherester composition and articles comprising the same | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-06-24 | — | — | US | claimed |
| US-20130327558-A1 | HALOGEN FREE FLAME RETARDANT THERMOPLASTIC ELASTOMER COMPOSITIONS HAVING IMPROVED INSULATION RESISTANCE | DUPONT POLYMERS, INC. | 2013-12-12 | — | — | US | claimed |
| WO-2013184631-A2 | HALOGEN FREE FLAME RETARDANT THERMOPLASTIC ELASTOMER COMPOSITIONS HAVING IMPROVED INSULATION RESISTANCE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-12-12 | — | — | WO | claimed |
| US-20130149533-A1 | FLAME-RETARDANT COPOLYETHERESTER COMPOSITION AND ARTICLES COMPRISING THE SAME | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-13 | — | — | US | claimed |
| WO-2013085725-A1 | FLAME-RETARDANT COPOLYETHERESTER COMPOSITION AND ARTICLES COMPRISING THE SAME | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-13 | — | — | WO | claimed |
| WO-2013085724-A1 | FLAME-RETARDANT COPOLYETHERESTER COMPOSITION AND ARTICLES COMPRISING THE SAME | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-13 | — | — | WO | claimed |
| US-20130146330-A1 | FLAME-RETARDANT COPOLYETHERESTER COMPOSITION AND ARTICLES COMPRISING THE SAME | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-13 | — | — | US | claimed |
| US-8258216-B2 | Thermosetting resin compositions and articles | PARK ELECTROCHEMICAL CORPORATION (US) | 2012-09-04 | — | — | US | claimed |
| WO-2011025961-A2 | THERMOSETTING RESIN COMPOSITIONS AND ARTICLES | PARK ELECTROCHEMICAL CORPORATION (US) | 2011-03-03 | — | — | WO | claimed |
| US-20110048776-A1 | THERMOSETTING RESIN COMPOSITIONS AND ARTICLES | PARK ELECTROCHEMICAL CORPORATION (US) | 2011-03-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240174623-A1 | Build UP Film Curable Compositions | CBX7, CBX4, CBX2 | SRC 3264/4885INPPL1 1472/4885INPP5A 1699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.